Federico Girardi, MD
Orthopaedic Surgery of the Spine · New York, NYNPI 1326086414
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $133,505 of the $143,761 with a category attached, or 92.9%. Ortho Development Corporation accounts for 87.6% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $31,551 and has fallen 64.8% since, to $11,098 in 2025.
Across 208 payments — averaging $691.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ortho Development Corporation$126K
- Zimmer Biomet$10K
- Alphatec Spine, Inc$4K
- Orthofix Medical, Inc.$2K
- Seaspine Orthopedics Corporation$1K
- Johnson & Johnson$448
- plus $594 from 2 others
What the payments were for
- Royalty or licence$133,50593%
- Consulting fees$3,6253%
- Travel & lodging$4,5613%
- Food & beverage$2,0701%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ortho Development Corporation | 158 | $125,981 |
| Zimmer Biomet | 5 | $9,539 |
| Alphatec Spine, Inc | 5 | $3,574 |
| Orthofix Medical, Inc. | 4 | $2,250 |
| Seaspine Orthopedics Corporation | 2 | $1,375 |
| Johnson & Johnson(2 entities) | 31 | $448 |
| Choice Spine, LLC | 1 | $364 |
| Globus Medical | 2 | $230 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Pagoda$110,654
- Spinal Rod$12,883
- Alpine XC$9,539
- Other - Miscellaneous$3,052
- Blackhawk$364
- Tiger Shark$364
- Blackbird$364
- Tomcat$364
- VEO$364
- Vusion OS$186
- Pulse$167
- CONDUIT$119
- Vivigen MIS Delivery System$116
- SYMPHONY$116
How this compares
$143,761 in reported general payments places this provider in the 85th percentile of 161 orthopaedic surgery of the spine providers in New York.
See all orthopaedic surgery of the spine providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 109 | $969 |
| Oxycodone Hcl | 76 | $490 |
| Methocarbamol | 24 | $198 |
| Pregabalin | 29 | $182 |
| Gabapentin | 19 | $173 |
| Hydromorphone Hcl | 18 | $99 |
| Tramadol Hcl | 20 | $61 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in New York
- Frank SchwabNew York$5.1M
- Han KimNew York$3.9M
- Todd AlbertNew York$2.7M
- Jeffrey SpivakNew York$1.3M
- Aaron BucklandNew York$1M
- Sheeraz QureshiNew York$828K
- Jeffrey GoldsteinNew York$765K
- Fabien BitanNew York$624K
- Oheneba Boachie-AdjeiNew York$313K
- Harvinder SandhuNew York$266K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.